Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Japan Society for the Promotion of Science, Tokyo, Japan.
Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Respir Med. 2021 Aug-Sep;185:106515. doi: 10.1016/j.rmed.2021.106515. Epub 2021 Jun 18.
Although previous cross-sectional studies showed the feasibility and clinical association of the St. George's Respiratory Questionnaire (SGRQ) in Mycobacterium avium complex pulmonary disease (MAC-PD), its longitudinal validity is poorly understood. We aimed to determine the longitudinal validity and prognostic significance of SGRQ.
In this prospective observational study conducted between May 2012 and August 2018, we evaluated 269 enrolled patients with MAC-PD and examined associations between baseline SGRQ total scores and mortality or clinical variables (anchors), including serum C-reactive protein levels and pulmonary function test results.
Age- and sex-matched SGRQ scores indicated significantly greater impairment in patients with MAC-PD than in the general population (P < 0.001). On multivariable Cox proportional hazards regression analysis, the SGRQ total score ≥25 was an independent risk factor for mortality (adjusted hazard ratio, 5.90; 95% confidence interval, 1.65-37.7) as well as age, body mass index, and forced vital capacity (FVC). Mixed-effect model results showed a significant association between SGRQ symptom/total scores and forced expiratory volume in 1 s (FEV), FVC, and diffusing carbon monoxide capacity. Older age, a positive smear, non-nodular/bronchiectatic form, and cavity regions were associated with SGRQ total score deterioration. Patients with a greater decline from baseline FEV (% predicted) exhibited significantly worse impairment in the SGRQ total score (mean ± SE, 4.69 ± 10.9 points, P = 0.001).
SGRQ showed longitudinal validity in assessing disease severity and was sensitive to changes in patients with MAC-PD, especially changes in %FEV The SGRQ total score may be an important prognostic factor.
尽管先前的横断面研究表明圣乔治呼吸问卷(SGRQ)在鸟分枝杆菌复合群肺病(MAC-PD)中的可行性和临床相关性,但它的纵向有效性知之甚少。我们旨在确定 SGRQ 的纵向有效性和预后意义。
在这项于 2012 年 5 月至 2018 年 8 月期间进行的前瞻性观察研究中,我们评估了 269 名 MAC-PD 患者,并检查了基线 SGRQ 总分与死亡率或临床变量(锚)之间的关联,包括血清 C 反应蛋白水平和肺功能测试结果。
年龄和性别匹配的 SGRQ 评分表明 MAC-PD 患者的损伤明显大于一般人群(P<0.001)。在多变量 Cox 比例风险回归分析中,SGRQ 总分≥25 是死亡率的独立危险因素(调整后的危险比,5.90;95%置信区间,1.65-37.7),以及年龄、体重指数和用力肺活量(FVC)。混合效应模型结果显示 SGRQ 症状/总分与 1 秒用力呼气量(FEV)、FVC 和一氧化碳弥散量之间存在显著关联。年龄较大、涂片阳性、非结节/支气管扩张型和空洞区与 SGRQ 总分恶化有关。从基线 FEV(%预测)下降较大的患者在 SGRQ 总分方面表现出明显更严重的损害(平均±SE,4.69±10.9 分,P=0.001)。
SGRQ 在评估疾病严重程度方面具有纵向有效性,对 MAC-PD 患者的变化敏感,特别是在%FEV 方面。SGRQ 总分可能是一个重要的预后因素。